A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
Phase
N/ASpan
241 weeksSponsor
AbbVieHohen Neuendorf
Recruiting
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Phase
N/ASpan
217 weeksSponsor
AbbVieHohen Neuendorf, Brandenburg
Recruiting
1-2 of 2